SLV 305
Latest Information Update: 10 Oct 2002
At a glance
- Originator Solvay
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders
Most Recent Events
- 16 Sep 2002 Discontinued - Phase-II for Gastrointestinal disorders in USA (unspecified route)
- 30 Aug 2000 Phase-II clinical trials in Gastrointestinal disorders in USA (unspecified route)
- 30 Aug 2000 New profile